Solventum Co. (NYSE:SOLV) Given Consensus Recommendation of “Reduce” by Brokerages

Shares of Solventum Co. (NYSE:SOLV) have received a consensus recommendation of “Reduce” from the six analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $58.00.

SOLV has been the subject of several recent research reports. Argus initiated coverage on shares of Solventum in a report on Monday, June 24th. They issued a “hold” rating for the company. Edward Jones initiated coverage on shares of Solventum in a report on Tuesday, April 2nd. They issued a “hold” rating for the company. Morgan Stanley reduced their price target on shares of Solventum from $70.00 to $55.00 and set an “equal weight” rating for the company in a report on Monday, July 15th. The Goldman Sachs Group reduced their price target on shares of Solventum from $54.00 to $48.00 and set a “sell” rating for the company in a report on Wednesday, July 10th. Finally, Bank of America reduced their price target on shares of Solventum from $70.00 to $60.00 and set a “neutral” rating for the company in a report on Tuesday, June 25th.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of SOLV. Partnership Wealth Management LLC bought a new position in shares of Solventum during the 2nd quarter worth approximately $26,000. Richard W. Paul & Associates LLC acquired a new position in Solventum during the 2nd quarter valued at approximately $26,000. Family Firm Inc. acquired a new position in Solventum during the 2nd quarter valued at approximately $26,000. M&R Capital Management Inc. acquired a new position in Solventum during the 2nd quarter valued at approximately $27,000. Finally, Beach Investment Counsel Inc. PA acquired a new position in Solventum during the 2nd quarter valued at approximately $27,000.

Solventum Price Performance

Solventum stock opened at $57.56 on Friday. The company has a debt-to-equity ratio of 2.16, a current ratio of 1.81 and a quick ratio of 1.33. Solventum has a 1 year low of $47.16 and a 1 year high of $96.05. The firm has a 50-day moving average of $54.69.

Solventum (NYSE:SOLV) last released its quarterly earnings data on Thursday, May 9th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.67 by $0.41. The company had revenue of $2.02 billion during the quarter, compared to analysts’ expectations of $1.99 billion. Equities analysts forecast that Solventum will post 6.25 EPS for the current fiscal year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.